Matthew Farrer, PhD, Imperial College
Affiliations: | Neurogenetics and Translational Medicine | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
Neurodegenerative diseasesWebsite:
http://www.cmmt.ubc.ca/research/investigators/farrer/labGoogle:
"Matthew Farrer"Mean distance: 19.3 (cluster 28)
Cross-listing: Alzheimer's Tree
Children
Sign in to add traineeIgor Tatarnikov | grad student | 2015- | UBC (FlyTree) |
Stefano Cataldi | grad student | 2014-2018 | UBC (FlyTree) |
Bahareh Behrouz | post-doc | 2008-2010 | Mayo Clinic Jacksonville |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lai D, Alipanahi B, Fontanillas P, et al. (2021) Genome-wide association studies of LRRK2 modifiers of Parkinson's disease. Annals of Neurology |
Bentley SR, Guella I, Sherman HE, et al. (2021) Hunting for Familial Parkinson's Disease Mutations in the Post Genome Era. Genes. 12 |
Lin CH, Farrer MJ, Wu RM. (2021) Reply: UQCRC1 variants in Parkinson's disease: a large cohort study in the Chinese mainland. Brain : a Journal of Neurology |
Kuhlmann N, Wagner Valladolid M, Quesada-Ramírez L, et al. (2021) Chronic and Acute Manipulation of Cortical Glutamate Transmission Induces Structural and Synaptic Changes in Co-cultured Striatal Neurons. Frontiers in Cellular Neuroscience. 15: 569031 |
Bu M, Farrer MJ, Khoshbouei H. (2021) Dynamic control of the dopamine transporter in neurotransmission and homeostasis. Npj Parkinson's Disease. 7: 22 |
Follett J, Farrer MJ. (2021) LRRK2; a dynamic regulator of cellular trafficking. Brain Research. 1761: 147394 |
Robert J, Weilinger NL, Cao LP, et al. (2020) An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Molecular Neurodegeneration. 15: 70 |
Lin CH, Tsai PI, Lin HY, et al. (2020) Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain : a Journal of Neurology |
Lüth T, König IR, Grünewald A, et al. (2020) Age at Onset of LRRK2 p.Gly2019Ser Is Related to Environmental and Lifestyle Factors. Movement Disorders : Official Journal of the Movement Disorder Society |
Brown EE, Blauwendraat C, Trinh J, et al. (2020) Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease. Neurobiology of Aging |